Dr Stephen Dobbin
- Honorary Clinical Research Fellow (School of Cardiovascular & Metabolic Health)
email:
Stephen.Dobbin@glasgow.ac.uk
Cardiology Department, Queen Elizabeth University Hospital, Govan Road, Glasgow, G51
Publications
2025
Glen, C. et al. (2025) Prospective evaluation of the cardiovascular effects of BRAF and MEK inhibitors in patients with melanoma. JACC: CardioOncology, (Accepted for Publication)
Dobbin, S. J. H. et al. (2025) Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging. Heart, (doi: 10.1136/heartjnl-2024-325535) (PMID:40180444) (Early Online Publication)
2023
Lees, Jennifer S. ORCID: https://orcid.org/0000-0001-6331-0178, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242, Elyan, Benjamin M.P.
ORCID: https://orcid.org/0000-0001-8848-1395, Gilmour, David F., Tomlinson, Laurie P., Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887 and Mark, Patrick B.
ORCID: https://orcid.org/0000-0003-3387-2123
(2023)
A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.
Nephrology Dialysis Transplantation, 38(7),
pp. 1666-1681.
(doi: 10.1093/ndt/gfac305)
(PMID:36318455)
(PMCID:PMC10310520)
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Shen, Li, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Packer, Milton, Solomon, Scott D., McMurray, John J.V.
ORCID: https://orcid.org/0000-0002-6317-3975, Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887 and Jhund, Pardeep S.
ORCID: https://orcid.org/0000-0003-4306-5317
(2023)
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
European Journal of Heart Failure, 25(4),
pp. 488-496.
(doi: 10.1002/ejhf.2818)
(PMID:36919816)
2022
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Sandra M.S., Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887, Herrmann, Joerg and Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887
(2022)
Hypertension and renal disease before anti-cancer therapies.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 111-122.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00020-9)
Herrmann, Sandra M.S., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Joerg, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2022)
Hypertension and renal disease during anti-cancer therapies.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 185-199.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00029-5)
Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Sandra M.S., Herrmann, Joerg and Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887
(2022)
Hypertension and renal failure prevention and management after cancer therapy.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 286-291.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00041-6)
2021
van Dorst, Daan C.H., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Neves, Karla B.
ORCID: https://orcid.org/0000-0001-5158-9263, Herrmann, Joerg, Herrmann, Sandra M., Versmissen, Jorie, Mathijssen, Ron H.J., Danser, A.H. Jan and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Hypertension and prohypertensive antineoplastic therapies in cancer patients.
Circulation Research, 128(7),
pp. 1040-1061.
(doi: 10.1161/CIRCRESAHA.121.318051)
(PMID:33793337)
(PMCID:PMC8011349)
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Myles, Rachel C.
ORCID: https://orcid.org/0000-0003-4670-361X, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Cardiotoxic effects of angiogenesis inhibitors.
Clinical Science, 135(1),
pp. 71-100.
(doi: 10.1042/CS20200305)
(PMID:33404052)
(PMCID:PMC7812690)
2020
Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242 and Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496
(2020)
Vericiguat in worsening heart failure – agonising over, or celebrating, agonism.
Cardiovascular Research, 116(12),
e152-e155.
(doi: 10.1093/cvr/cvaa247)
(PMID:32980877)
Dobbin, S. J.H. et al. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22(7), pp. 1276-1277. (doi: 10.1002/ejhf.1847) (PMID:32379945)
2018
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Cameron, Alan C., Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Jones, Robert J.
ORCID: https://orcid.org/0000-0002-2904-6980, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2018)
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors.
Heart, 104(24),
pp. 1995-2002.
(doi: 10.1136/heartjnl-2018-313726)
(PMID:30228246)
(PMCID:PMC6268130)
Evans, Jonathan D.W., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Pettit, Stephen J., Di Angelantonio, Emanuele and Willeit, Peter
(2018)
High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events.
JACC: Heart Failure, 6(3),
pp. 187-197.
(doi: 10.1016/j.jchf.2017.11.003)
(PMID:29331272)
Dobbin, Stephen ORCID: https://orcid.org/0000-0002-9111-0242, Fisher, Miles and McKay, Gerry
ORCID: https://orcid.org/0009-0006-5572-5246
(2018)
Management of atrial fibrillation in diabetes.
Practical Diabetes, 35(1),
pp. 27-31.
(doi: 10.1002/pdi.2155)
2017
Dobbin, S.J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Petrie, J.R.
ORCID: https://orcid.org/0000-0002-4894-9819, Lean, M.E.J.
ORCID: https://orcid.org/0000-0003-2216-0083 and McKay, G.A.
ORCID: https://orcid.org/0009-0006-5572-5246
(2017)
Fludrocortisone therapy for persistent hyperkalaemia.
Diabetic Medicine, 34(7),
pp. 1005-1008.
(doi: 10.1111/dme.13359)
(PMID:28375568)
2016
Dobbin, Stephen ORCID: https://orcid.org/0000-0002-9111-0242, McKay, Gerry
ORCID: https://orcid.org/0009-0006-5572-5246 and Fisher, Miles
(2016)
Aliskiren update.
Practical Diabetes, 33(6),
pp. 214-215.
(doi: 10.1002/pdi.2041)
2015
Badar, A. A. et al. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13(8), pp. 915-922. (doi: 10.1586/14779072.2015.1067139) (PMID:26163051)
Articles
Glen, C. et al. (2025) Prospective evaluation of the cardiovascular effects of BRAF and MEK inhibitors in patients with melanoma. JACC: CardioOncology, (Accepted for Publication)
Dobbin, S. J. H. et al. (2025) Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging. Heart, (doi: 10.1136/heartjnl-2024-325535) (PMID:40180444) (Early Online Publication)
Lees, Jennifer S. ORCID: https://orcid.org/0000-0001-6331-0178, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242, Elyan, Benjamin M.P.
ORCID: https://orcid.org/0000-0001-8848-1395, Gilmour, David F., Tomlinson, Laurie P., Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887 and Mark, Patrick B.
ORCID: https://orcid.org/0000-0003-3387-2123
(2023)
A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.
Nephrology Dialysis Transplantation, 38(7),
pp. 1666-1681.
(doi: 10.1093/ndt/gfac305)
(PMID:36318455)
(PMCID:PMC10310520)
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Shen, Li, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Packer, Milton, Solomon, Scott D., McMurray, John J.V.
ORCID: https://orcid.org/0000-0002-6317-3975, Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887 and Jhund, Pardeep S.
ORCID: https://orcid.org/0000-0003-4306-5317
(2023)
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
European Journal of Heart Failure, 25(4),
pp. 488-496.
(doi: 10.1002/ejhf.2818)
(PMID:36919816)
van Dorst, Daan C.H., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Neves, Karla B.
ORCID: https://orcid.org/0000-0001-5158-9263, Herrmann, Joerg, Herrmann, Sandra M., Versmissen, Jorie, Mathijssen, Ron H.J., Danser, A.H. Jan and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Hypertension and prohypertensive antineoplastic therapies in cancer patients.
Circulation Research, 128(7),
pp. 1040-1061.
(doi: 10.1161/CIRCRESAHA.121.318051)
(PMID:33793337)
(PMCID:PMC8011349)
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Myles, Rachel C.
ORCID: https://orcid.org/0000-0003-4670-361X, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Cardiotoxic effects of angiogenesis inhibitors.
Clinical Science, 135(1),
pp. 71-100.
(doi: 10.1042/CS20200305)
(PMID:33404052)
(PMCID:PMC7812690)
Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242 and Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496
(2020)
Vericiguat in worsening heart failure – agonising over, or celebrating, agonism.
Cardiovascular Research, 116(12),
e152-e155.
(doi: 10.1093/cvr/cvaa247)
(PMID:32980877)
Dobbin, S. J.H. et al. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22(7), pp. 1276-1277. (doi: 10.1002/ejhf.1847) (PMID:32379945)
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Cameron, Alan C., Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496, Jones, Robert J.
ORCID: https://orcid.org/0000-0002-2904-6980, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2018)
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors.
Heart, 104(24),
pp. 1995-2002.
(doi: 10.1136/heartjnl-2018-313726)
(PMID:30228246)
(PMCID:PMC6268130)
Evans, Jonathan D.W., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Pettit, Stephen J., Di Angelantonio, Emanuele and Willeit, Peter
(2018)
High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events.
JACC: Heart Failure, 6(3),
pp. 187-197.
(doi: 10.1016/j.jchf.2017.11.003)
(PMID:29331272)
Dobbin, Stephen ORCID: https://orcid.org/0000-0002-9111-0242, Fisher, Miles and McKay, Gerry
ORCID: https://orcid.org/0009-0006-5572-5246
(2018)
Management of atrial fibrillation in diabetes.
Practical Diabetes, 35(1),
pp. 27-31.
(doi: 10.1002/pdi.2155)
Dobbin, S.J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Petrie, J.R.
ORCID: https://orcid.org/0000-0002-4894-9819, Lean, M.E.J.
ORCID: https://orcid.org/0000-0003-2216-0083 and McKay, G.A.
ORCID: https://orcid.org/0009-0006-5572-5246
(2017)
Fludrocortisone therapy for persistent hyperkalaemia.
Diabetic Medicine, 34(7),
pp. 1005-1008.
(doi: 10.1111/dme.13359)
(PMID:28375568)
Dobbin, Stephen ORCID: https://orcid.org/0000-0002-9111-0242, McKay, Gerry
ORCID: https://orcid.org/0009-0006-5572-5246 and Fisher, Miles
(2016)
Aliskiren update.
Practical Diabetes, 33(6),
pp. 214-215.
(doi: 10.1002/pdi.2041)
Badar, A. A. et al. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13(8), pp. 915-922. (doi: 10.1586/14779072.2015.1067139) (PMID:26163051)
Book Sections
Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Sandra M.S., Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887, Herrmann, Joerg and Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887
(2022)
Hypertension and renal disease before anti-cancer therapies.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 111-122.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00020-9)
Herrmann, Sandra M.S., Dobbin, Stephen J.H. ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Joerg, Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2022)
Hypertension and renal disease during anti-cancer therapies.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 185-199.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00029-5)
Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Dobbin, Stephen J.H.
ORCID: https://orcid.org/0000-0002-9111-0242, Herrmann, Sandra M.S., Herrmann, Joerg and Touyz, Rhian M.
ORCID: https://orcid.org/0000-0003-0670-0887
(2022)
Hypertension and renal failure prevention and management after cancer therapy.
In: Herrmann, Joerg (ed.)
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease.
Elsevier: Philadelphia, PA, pp. 286-291.
ISBN 9780323681353
(doi: 10.1016/B978-0-323-68135-3.00041-6)